Pedersen, Nina G.
3979  results:
Search for persons X
?
1

Plasma progesterone, estradiol, and unconjugated estriol co..:

Johnsson, Vilma L. ; Pedersen, Nina G. ; Worda, Katharina...
Acta Obstetricia et Gynecologica Scandinavica.  98 (2018)  1 - p. 86-94 , 2018
 
?
5

Solid lipid nanoparticles can effectively bind DNA, strepta..:

Pedersen, Nina ; Hansen, Susan ; Heydenreich, Annette V...
European Journal of Pharmaceutics and Biopharmaceutics.  62 (2006)  2 - p. 155-162 , 2006
 
?
6

Global evolutionary analysis of chronic hepatitis C patient..:

Fahnøe, Ulrik ; Pedersen, Martin S ; Sølund, Christina...
https://orbit.dtu.dk/en/publications/30119457-e631-4bd0-ab35-5e05e8538ae1.  , 2021
 
?
7

Global evolutionary analysis of chronic hepatitis C patient..:

Fahnøe, Ulrik ; Pedersen, Martin S ; Sølund, Christina...
https://vbn.aau.dk/da/publications/d68cf4b5-9f6e-4656-8294-9fae6c7a03ef.  , 2021
 
?
8

Global evolutionary analysis of chronic hepatitis C patient..:

Fahnøe, Ulrik ; Pedersen, Martin S ; Sølund, Christina...
Fahnøe , U , Pedersen , M S , Sølund , C , Ernst , A , Krarup , H B , Røge , B T , Christensen , P B , Laursen , A L , Gerstoft , J , Thielsen , P , Madsen , L G , Pedersen , A G , Schønning , K , Weis , N & Bukh , J 2021 , ' Global evolutionary analysis of chronic hepatitis C patients revealed significant effect of baseline viral resistance, including novel non-target sites, for DAA-based treatment and retreatment outcome ' , Journal of Viral Hepatitis , vol. 28 , no. 2 , pp. 302-316 . https://doi.org/10.1111/jvh.13430.  , 2021
 
?
9

Global evolutionary analysis of chronic hepatitis C patient..:

Fahnøe, Ulrik ; Pedersen, Martin S ; Sølund, Christina...
Fahnøe , U , Pedersen , M S , Sølund , C , Ernst , A , Krarup , H B , Røge , B T , Christensen , P B , Laursen , A L , Gerstoft , J , Thielsen , P , Madsen , L G , Pedersen , A G , Schønning , K , Weis , N & Bukh , J 2021 , ' Global evolutionary analysis of chronic hepatitis C patients revealed significant effect of baseline viral resistance, including novel non-target sites, for DAA-based treatment and retreatment outcome ' , Journal of Viral Hepatitis , vol. 28 , no. 2 , pp. 302-316 . https://doi.org/10.1111/jvh.13430.  , 2021
 
1-15